CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 39,220	$ 55,699
Accounts receivable	1,145	1,070
Marketable securities	23,731	46,361
Research and development incentive receivable	720	640
Inventory	3,170	2,817
Prepaid expenses and other current assets	4,956	5,588
Total current assets	72,942	112,175
Property and equipment, net	254	776
Goodwill	17,351	17,351
Intangible asset, net	9,625	10,000
Right-of-use assets	2,646	4,065
Other assets	2,350	2,080
Total assets	105,168	146,447
Current liabilities:
Accounts payable	7,709	8,621
Accrued expenses (Note 9)	13,065	23,005
Deferred revenue	754	0
Current portion of lease liability	1,368	1,251
Total current liabilities	22,896	32,877
Long-term debt, including accretion, net of discount (Note 10)	75,841	75,425
Lease liabilities	815	1,410
Warrant liability (Note 5)	283	13,755
Deferred revenue	827	0
Other liabilities	535	831
Total liabilities	101,197	124,298
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $0.001 par value. 10,000,000 shares authorized and no shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	0	0
Common stock, $0.001 par value, 500,000,000 shares authorized as of June 30, 2025 and December 31, 2024, respectively; 7,959,947 and 5,698,231 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	8	6
Additional paid-in capital	544,915	537,620
Accumulated other comprehensive loss	(138)	(122)
Accumulated deficit	(540,814)	(515,355)
Total stockholders’ equity	3,971	22,149
Total liabilities and stockholders’ equity	$ 105,168	$ 146,447